<DOC>
	<DOCNO>NCT02856555</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability GS-0976 adult nonalcoholic steatohepatitis ( NASH ) .</brief_summary>
	<brief_title>GS-0976 Adults With Nonalcoholic Steatohepatitis</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Key Meets follow condition : A clinical diagnosis nonalcoholic fatty liver disease ( NAFLD ) Screening magnetic resonance image proton density fat fraction ( MRIPDFF ) ≥ 8 % steatosis Screening magnetic resonance elastography ( MRE ) liver stiffness ≥ 2.5 kPa OR A historical liver biopsy consistent NASH noncirrhotic fibrosis Platelet count ≥ 100,000/mm^3 Creatinine Clearance ( CLcr ) calculate CockcroftGault equation ≥ 60 ml/min Key Pregnant lactate female Alanine aminotransferase ( ALT ) &gt; 5 x upper limit normal range ( ULN ) Other cause liver disease include autoimmune , viral , alcoholic liver disease Cirrhosis liver Prior history decompensated liver disease , include ascites , hepatic encephalopathy variceal bleed Body mass index ( BMI ) &lt; 18 kg/m^2 International normalized ratio ( INR ) &gt; 1.2 unless anticoagulant therapy Total bilirubin &gt; 1 x ULN , except diagnosis Gilbert 's syndrome NOTE : Other protocol define Inclusion/ Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>